CBD and cannabis have been studied in other specific cancers. A 2013 study published in the journal Chemotherapy studied the effects of synthetic THC against gastric cancer grafts in rodents. Rodents treated with the THC saw a 30 percent reduction in tumor growth over 14 days of treatment when compared to the control. A 2012 Journal of Molecular Medicine study found tumors in mice with laboratory-induced colon cancer shrunk with CBD treatment. A 2013 study published in Molecular Cancer Therapeutics found that CBD triggers cell death in certain lung cancer cell lines, decreasing tumor viability.
Cannabidiol (CBD) is one of dozens of non-psychoactive cannabinoids found in the hemp plant. Cannabidiol, and all the other cannabinoids, were patented by the United States Government in 2003 as neuroprotectants and antioxidants (Patent No. 6,630,507). Cannabinoids are characterized by their ability to act on the cannabinoid receptors that are found throughout the body. CBD and other cannabinoids are naturally occurring compounds that display potent anti-inflammatory and pain-relieving properties. They can promote the body’s healthy regulation of the central nervous, immune, and endocannabinoid systems.